Clinical, diagnostic and therapeutic approaches to complications of brucellosis: an experience of 12 years

Med Princ Pract. 2012;21(1):46-50. doi: 10.1159/000331588. Epub 2011 Oct 21.

Abstract

Objective: To describe the clinical presentations, laboratory findings, prevalence and pattern of complications and the response to treatment of brucellosis in a 12-year period in a Turkish research hospital.

Materials and methods: Between 1996 and 2008, 231 patients were diagnosed with brucellosis and treated in our clinic. Medical records of 189 of the 231 patients with at least one demonstrable complication of the disease were reviewed for anamnesis, diagnosis, complications, treatment and clinical outcomes.

Results: The decreasing order of the complications was: hematological, 104 (55%); osteoarticular, 70 (37%); hepatobiliary, 59 (31%), and gastrointestinal, 23 (12%). The most common laboratory findings were anemia, lymphomonocytosis, elevated sedimentation rate and C-reactive protein, and elevated aminotransaminases.

Conclusion: The hematological, osteoarticular and hepatobiliary manifestations were predominant. Bursitis, synovitis, glomerulonephritis, cutaneous lesion and deep vein thrombosis were the rare complications observed in our study. In clinical practice, brucellosis should be considered in the differential diagnosis in the presence of infrequent complications.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Bacterial Agents / therapeutic use*
  • Blood Sedimentation
  • Brucellosis / complications*
  • Brucellosis / diagnosis
  • Brucellosis / drug therapy*
  • C-Reactive Protein / metabolism
  • Diagnosis, Differential
  • Doxycycline / therapeutic use
  • Female
  • Gastrointestinal Diseases / diagnosis
  • Gastrointestinal Diseases / drug therapy*
  • Gastrointestinal Diseases / epidemiology
  • Gastrointestinal Diseases / microbiology
  • Hematologic Diseases / diagnosis
  • Hematologic Diseases / drug therapy*
  • Hematologic Diseases / epidemiology
  • Hematologic Diseases / microbiology
  • Humans
  • Joint Diseases / diagnosis
  • Joint Diseases / drug therapy*
  • Joint Diseases / epidemiology
  • Joint Diseases / microbiology
  • Male
  • Middle Aged
  • Prevalence
  • Retrospective Studies
  • Rifampin / therapeutic use
  • Streptomycin / therapeutic use
  • Time Factors
  • Turkey
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • C-Reactive Protein
  • Doxycycline
  • Rifampin
  • Streptomycin